000 03916nam a22004695i 4500
001 978-3-031-58799-3
003 DE-He213
005 20251030112900.0
007 cr nn 008mamaa
008 240820s2024 sz | s |||| 0|eng d
020 _a9783031587993
_9978-3-031-58799-3
024 7 _a10.1007/978-3-031-58799-3
_2doi
050 4 _aRE1-994
072 7 _aMJQ
_2bicssc
072 7 _aMED063000
_2bisacsh
072 7 _aMJQ
_2thema
100 1 _aWeiss, Jeffrey N.
_eauthor.
_4aut
_4http://id.loc.gov/vocabulary/relators/aut
_979862
245 1 0 _aClinical Trials in Retinitis Pigmentosa Treatment
_h[electronic resource] /
_cby Jeffrey N. Weiss.
250 _a1st ed. 2024.
264 1 _aCham :
_bSpringer Nature Switzerland :
_bImprint: Springer,
_c2024.
300 _aXII, 286 p. 4 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _aPart 1: Introduction -- Chapter 1. Introduction to Retinitis Pigmentosa -- Chapter 2. Treatments -- Chapter 3. Notes -- Part 2: Completed Clinical Trials -- Chapter 4. United States -- Chapter 5. Brazil -- Chapter 6. Turkey -- Part 3: Active, Recruiting Clinical Trials -- Chapter 7. United States -- Chapter 8. Latin America -- Chapter 9. Turkey -- Part 4: Not Yet Recruiting Clinical Trials -- Chapter 10. Indonesia -- Part 5: Active, Not Recruiting -- Chapter 11. United States -- Chapter 12. France -- Part 6: Enrolling by Invitation -- Chapter 13. United States -- Chapter 14. Indonesia -- Part 7: Gene Therapy Studies -- Chapter 15. United States/Europe -- Chapter 16. India -- Chapter 17. Saudi Arabia -- Part 8: Active, Recruiting Gene Therapy Studies -- Chapter 18. United States -- Chapter 19. China -- Part 9: Active, Not Recruiting Gene Therapy Studies -- Chapter 20. United States -- Chapter 21. Germany -- Chapter 22. Sweden -- Part 10: Enrolling by Invitation Gene Therapy Studies -- Chapter 23. Americas/Europe -- Chapter 24. India -- Part 11: Optogenetics -- Chapter 25. Active Trials in United States -- Part 12: Other Treatments -- Chapter 26. Completed Trials in The Americas/Europe -- Chapter 27. Completed Trials in China -- Chapter 28. Completed Trials in Italy -- Chapter 29. Completed Trials in Turkey -- Chapter 30. Active Trials in the United States -- Chapter 31. Active Trials in Australia -- Chapter 32. Active Trials in China -- Chapter 33. Active, Not Recruiting Trials in the US/Europe -- Chapter 34. Not Yet Recruiting Trials in China.
520 _aThis book is a compendium of the worldwide ocular stem cell, gene therapy, optogenetic, and other miscellaneous studies treating Retinitis Pigmentosa registered with Clinicaltrials.gov. Clinicaltrials.gov is the largest website listing of registered clinical research studies in the world. The study title and the Clinical Trial Number is provided in order to make it easier for the reader to obtain further information. The book contains chapters that act as an introduction to Retinitis Pigmentosa, as well as discussion and analysis of the studies. References are also included for the readers’ use. Clinical Trials in Retinitis Pigmentosa Treatment is a valuable resource for ophthalmologists, optometrists, other physicians, and researchers.
650 0 _aOphthalmology.
_972072
650 1 4 _aOphthalmology.
_972072
710 2 _aSpringerLink (Online service)
773 0 _tSpringer Nature eBook
776 0 8 _iPrinted edition:
_z9783031587986
776 0 8 _iPrinted edition:
_z9783031588006
776 0 8 _iPrinted edition:
_z9783031588013
856 4 0 _uhttps://doi.org/10.1007/978-3-031-58799-3
912 _aZDB-2-SME
912 _aZDB-2-SXM
999 _c62571
_d62571